Evaluating methods to improve outcomes for premature babies through placental transfusion techniques
Evaluation of Placental Transfusion Techniques in of Prematurity Related Complications and Hematological Profile
This study is testing different ways to give blood from the placenta to premature babies to see which method helps them stay healthier in their first days of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 160 (estimated) |
| Ages | 1 Minute to 2 Minutes |
| Sex | All |
| Sponsor | Alexandria University Academic / other |
| Locations | 1 site (Alexandria) |
| Trial ID | NCT06812507 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the effectiveness of different placental transfusion methods, including intact umbilical cord milking, cut umbilical cord milking, and delayed cord clamping, in preventing complications associated with prematurity in neonates. The research will monitor premature infants born at or before 32 weeks of gestation during their initial days of life in a neonatal intensive care unit. By comparing these techniques, the study seeks to determine which method may provide the best outcomes for these vulnerable patients.
Who should consider this trial
Good fit: Ideal candidates for this study are premature neonates born at or before 32 weeks of gestation who will be admitted to a neonatal intensive care unit within their first day of life.
Not a fit: Patients who are born after 32 weeks of gestation or have major congenital anomalies will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved health outcomes and reduced complications for premature infants.
How similar studies have performed: Other studies have shown promising results with similar placental transfusion techniques, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
* Inclusion Criteria: 1. Premature neonates ≤ 32 weeks gestational age regardless birth weight 2. patients should be admitted to neonatal intensive care unit in the first day of life of life Exclusion criteria: * Exclusion Criteria: Patient with any of the following will be excluded: 1. Major congenital anomalies (complex cyanotic heart disease, major central nervous system anomalies). 2. Evidence of head trauma causing major intracranial hemorrhage. 3. placental abnormalities like : abruptions, placenta previa or retroplacental hematoma. 4. Cord accident, or avulsion at the time of delivery. 5. Refusal to perform the intervention by the obstetrician
Where this trial is running
Alexandria
- Marwa Mohamed Farag — Alexandria, Egypt (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.